Literature DB >> 32366534

Intracranial hemodynamic relationships in patients with cerebral small vessel disease.

Gordon W Blair1, Michael J Thrippleton1, Yulu Shi1, Iona Hamilton1, Michael Stringer1, Francesca Chappell1, David Alexander Dickie1, Peter Andrews1, Ian Marshall1, Fergus N Doubal1, Joanna M Wardlaw2.   

Abstract

OBJECTIVE: To investigate cerebrovascular reactivity (CVR), blood flow, vascular and CSF pulsatility, and their independent relationship with cerebral small vessel disease (SVD) features in patients with minor ischemic stroke and MRI evidence of SVD.
METHODS: We recruited patients with minor ischemic stroke and assessed CVR using blood oxygen level-dependent MRI during a hypercapnic challenge, cerebral blood flow (CBF), vascular and CSF pulsatility using phase-contrast MRI, and structural magnetic resonance brain imaging to quantify white matter hyperintensities (WMHs) and perivascular spaces (PVSs). We used multiple regression to identify parameters associated with SVD features, controlling for patient characteristics.
RESULTS: Fifty-three of 60 patients completed the study with a full data set (age 68.0% ± 8.8 years, 74% male, 75% hypertensive). After controlling for age, sex, and systolic blood pressure, lower white matter CVR was associated with higher WMH volume (-0.01%/mm Hg per log10 increase in WMH volume, p = 0.02), basal ganglia PVS (-0.01%/mm Hg per point increase in the PVS score, p = 0.02), and higher venous pulsatility (superior sagittal sinus -0.03%/mm Hg, p = 0.02, per unit increase in the pulsatility index) but not with CBF (p = 0.58). Lower foramen magnum CSF stroke volume was associated with worse white matter CVR (0.04%/mm Hg per mL increase in stroke volume, p = 0.04) and more severe basal ganglia PVS (p = 0.09).
CONCLUSIONS: Lower CVR, higher venous pulsatility, and lower foramen magnum CSF stroke volume indicate that dynamic vascular dysfunctions underpin PVS dysfunction and WMH development. Further exploration of microvascular dysfunction and CSF dynamics may uncover new mechanisms and intervention targets to reduce SVD lesion development, cognitive decline, and stroke.
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

Entities:  

Year:  2020        PMID: 32366534     DOI: 10.1212/WNL.0000000000009483

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

Review 1.  Small Vessel Disease, a Marker of Brain Health: What the Radiologist Needs to Know.

Authors:  A Mahammedi; L L Wang; B J Williamson; P Khatri; B Kissela; R P Sawyer; R Shatz; V Khandwala; A Vagal
Journal:  AJNR Am J Neuroradiol       Date:  2021-10-07       Impact factor: 3.825

2.  Digoxin Ameliorates Glymphatic Transport and Cognitive Impairment in a Mouse Model of Chronic Cerebral Hypoperfusion.

Authors:  Jie Cao; Di Yao; Rong Li; Xuequn Guo; Jiahuan Hao; Minjie Xie; Jia Li; Dengji Pan; Xiang Luo; Zhiyuan Yu; Minghuan Wang; Wei Wang
Journal:  Neurosci Bull       Date:  2021-10-27       Impact factor: 5.203

Review 3.  The glymphatic system: implications for drugs for central nervous system diseases.

Authors:  Terhi J Lohela; Tuomas O Lilius; Maiken Nedergaard
Journal:  Nat Rev Drug Discov       Date:  2022-08-10       Impact factor: 112.288

4.  Autoregulation of White Matter Cerebral Blood Flow to Arterial Pressure Changes in Normal Subjects.

Authors:  William Powers; Hongyu An; Jonathan Oakes; Joseph Eron; Kevin Robertson; Souvik Sen
Journal:  J Neurol Disord Stroke       Date:  2021-12-14

Review 5.  Carotid revascularization and cognitive impairment: the neglected role of cerebral small vessel disease.

Authors:  Francesco Arba; Federica Vit; Mascia Nesi; Chiara Rinaldi; Mauro Silvestrini; Domenico Inzitari
Journal:  Neurol Sci       Date:  2021-10-01       Impact factor: 3.830

6.  Rationale and design of a longitudinal study of cerebral small vessel diseases, clinical and imaging outcomes in patients presenting with mild ischaemic stroke: Mild Stroke Study 3.

Authors:  Una Clancy; Daniela Jaime Garcia; Michael S Stringer; Michael J Thrippleton; Maria C Valdés-Hernández; Stewart Wiseman; Olivia Kl Hamilton; Francesca M Chappell; Rosalind Brown; Gordon W Blair; Will Hewins; Emilie Sleight; Lucia Ballerini; Mark E Bastin; Susana Munoz Maniega; Tom MacGillivray; Kirstie Hetherington; Charlene Hamid; Carmen Arteaga; Alasdair G Morgan; Cameron Manning; Ellen Backhouse; Iona Hamilton; Dominic Job; Ian Marshall; Fergus N Doubal; Joanna M Wardlaw
Journal:  Eur Stroke J       Date:  2020-06-05

7.  Cerebrovascular Reactivity Measurement Using Magnetic Resonance Imaging: A Systematic Review.

Authors:  Emilie Sleight; Michael S Stringer; Ian Marshall; Joanna M Wardlaw; Michael J Thrippleton
Journal:  Front Physiol       Date:  2021-02-25       Impact factor: 4.566

8.  Effects of Cilostazol and Isosorbide Mononitrate on Cerebral Hemodynamics in the LACI-1 Randomized Controlled Trial.

Authors:  Gordon W Blair; Esther Janssen; Michael S Stringer; Michael J Thrippleton; Francesca Chappell; Yulu Shi; Iona Hamilton; Katie Flaherty; Jason P Appleton; Fergus N Doubal; Philip M Bath; Joanna M Wardlaw
Journal:  Stroke       Date:  2021-12-01       Impact factor: 7.914

9.  Arterial Spin Labeling Imaging Assessment of Cerebrovascular Reactivity in Hypertensive Small Vessel Disease.

Authors:  Bo-Ching Lee; Hsin-Hsi Tsai; Abel Po-Hao Huang; Yen-Ling Lo; Li-Kai Tsai; Ya-Fang Chen; Wen-Chau Wu
Journal:  Front Neurol       Date:  2021-06-30       Impact factor: 4.003

10.  A Comparison of CVR Magnitude and Delay Assessed at 1.5 and 3T in Patients With Cerebral Small Vessel Disease.

Authors:  Michael S Stringer; Gordon W Blair; Yulu Shi; Iona Hamilton; David A Dickie; Fergus N Doubal; Ian M Marshall; Michael J Thrippleton; Joanna M Wardlaw
Journal:  Front Physiol       Date:  2021-06-02       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.